Alpha Tau Medical (DRTS) Stock Forecast, Price & News

Alpha Tau Medical (NASDAQ:DRTS) Frequently Asked Questions

Is Alpha Tau Medical a buy right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Alpha Tau Medical in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Alpha Tau Medical stock.
View analyst ratings for Alpha Tau Medical or view top-rated stocks.

When is Alpha Tau Medical's next earnings date?

Alpha Tau Medical is scheduled to release its next quarterly earnings announcement on Monday, June 27th 2022.
View our earnings forecast for Alpha Tau Medical.

What price target have analysts set for DRTS?

3 analysts have issued 1-year target prices for Alpha Tau Medical's stock. Their forecasts range from $19.00 to $21.00. On average, they expect Alpha Tau Medical's share price to reach $20.00 in the next year. This suggests a possible upside of 248.4% from the stock's current price.
View analysts' price targets for Alpha Tau Medical or view top-rated stocks among Wall Street analysts.

Who are Alpha Tau Medical's key executives?

Alpha Tau Medical's management team includes the following people:

• Mr. Uzi Sofer, CEO & Chairman (Age 52)
• Mr. Raphi Levy, Chief Financial Officer (Age 37)
• Mr. Amnon Gat, Chief Operations Officer (Age 47)
• Mr. Ronen Segal, Chief Technology Officer (Age 49)
• Prof. Yona Keisari, Chief Scientific Officer & Member of Scientific Advisory board (Age 75)
• Ms. Rebecca Becker, VP of legal
• Dr. Robert B. Den M.D., Chief Medical Officer & Member of Scientific Advisory Board (Age 43)
• Prof. Itzhak Kelson, Chief Physics Officer & Member of Scientific Advisory Board (Age 82)
• Ms. Yael Zeiger, Corp. Controller (Age 39)

Who are some of Alpha Tau Medical's key competitors?

Some companies that are related to Alpha Tau Medical include Paragon 28 (FNA), Atrion (ATRI), Silk Road Medical (SILK), LeMaitre Vascular (LMAT), Antares Pharma (ATRS), Intersect ENT (XENT), Cerus (CERS), Treace Medical Concepts (TMCI), OrthoPediatrics (KIDS), Longview Acquisition Corp. II (LGV), Alphatec (ATEC), Artivion (AORT), AngioDynamics (ANGO), Pulmonx (LUNG) and Bioventus (BVS).
View all of DRTS's competitors.

What is Alpha Tau Medical's stock symbol?

Alpha Tau Medical trades on the NASDAQ under the ticker symbol "DRTS."

Who are Alpha Tau Medical's major shareholders?

Alpha Tau Medical's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Ergoteles LLC (0.02%), Penserra Capital Management LLC (0.01%) and Clear Street LLC (0.00%).

Which institutional investors are buying Alpha Tau Medical stock?

DRTS stock was acquired by a variety of institutional investors in the last quarter, including Ergoteles LLC, Penserra Capital Management LLC, and Clear Street LLC.

How do I buy shares of Alpha Tau Medical?

Shares of DRTS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Alpha Tau Medical's stock price today?

One share of DRTS stock can currently be purchased for approximately $5.74.

How much money does Alpha Tau Medical make?

Alpha Tau Medical has a market capitalization of $381.88 million.

How many employees does Alpha Tau Medical have?

Alpha Tau Medical employs 83 workers across the globe.

What is Alpha Tau Medical's official website?

The official website for Alpha Tau Medical is healthcarecapitalcorp.com.

How can I contact Alpha Tau Medical?

Alpha Tau Medical's mailing address is 301 N. MARKET STREET STE 1414, WILMINGTON DE, 19801. The company can be reached via phone at 561-810-0031 or via email at [email protected].